Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial
Titel:
Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial
Auteur:
Devillier, Philippe Humbert, Marc Boye, Alain Zachgo, Wolfgang Jacques, Loretta Nunn, Carol West, Sarah Nicholls, Andy Antoun, Zeina Spinu, Luminita Grouin, Jean-Marie